WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO) is pleased to announce it will convene the inaugural Clinical Outsourcing Leaders Summit with a select group of senior pharmaceutical, biotech and clinical research executives November 13, 2008 in Washington, DC.
This exclusive event will feature high-level, interactive discussions surrounding the impact of the presidential election on biomedical research and various aspects of drug development. Among the featured speakers are:
Dr. Mark B. McClellan, Senior Fellow and Director of The Engelberg Center for Healthcare Reform at the Brookings Institution and former commissioner of the Food and Drug Administration;
Bill Thomas, former U.S. Congressman and former Chairman of the House Committee on Ways and Means. Currently a Senior Advisor to Buchanan, Ingersoll & Rooney PC and a Visiting Fellow at the American Enterprise Institute;
Dr. Andrew Dahlem, Vice President and COO, Eli Lilly Laboratories;
Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research at the Food and Drug Administration;
Ken Getz, founder and chairman of the nonprofit CISCRP and a Senior Research Fellow at the Tufts Center for Drug Development, Tufts University Medical School;
Chris Singer, Executive Vice President and COO of PhRMA;
David Spaight, Chair of the ACRO Board of Directors and President of MDS Pharma Services;
Dr. Dennis Gillings, founding Chair of ACRO and Chairman and CEO of Quintiles Transnational Corp.
"Regardless of the outcome of the November elections, we know the drug
development industry will face significant changes in the coming years,"
said ACRO Executive Director, Doug Peddicord, Ph.D. "This summit will bring
together thought leaders from the biopharmaceutical and clinical
outsourcing industries for an open dialogue on the political, economic and
regulatory aspects of the changing healt
|SOURCE Association of Clinical Research Organizations|
Copyright©2008 PR Newswire.
All rights reserved